💨 Abstract
Protara Therapeutics, Inc. (TARA) reported a second-quarter loss of $15 million, or 35 cents per share, exceeding Wall Street's expectations of a 43 cents per share loss. The results were based on data from Zacks Investment Research, highlighting the company's better-than-expected financial performance for the period.
Courtesy: WTOP Staff
Suggested
Schwarber hits his 42nd homer in a 4-run 8th inning as the Phillies rally past the Reds 4-1 -
Republicans, Democrats alike exhort Trump: Keep security pact with Australia and UK alive -
Nevada court apparently clears way for former Raiders coach Jon Gruden to sue NFL over emails -
Arkansas authorities say additional employees disciplined at prison where ex-police chief escaped -
Correa plays 1st game in Houston since trade as Bregman visits for 1st time since joining Red Sox -
Uvalde school district releases records for 2022 classroom shooting, after legal fight over access -
Empresa: Q2 Earnings Snapshot -
Veteran reliever Kendall Graveman designated for assignment by Diamondbacks -
Scientists search for DNA of an endangered salamander in Mexico City’s canals -
‘Never stop learning’: College professors give lectures in DC bars and cafes -